12 October 2015
Nanomedicine in the fight against thrombotic diseases: Examining current research into thrombus treatment
Ischemic heart disease and stroke caused by thrombus formation are responsible for more than 17 million deaths per year worldwide. Now researchers announce new research that has been covering the use of nanocarriers and microbubbles in drug delivery for thrombotic disease.
Categories
- Biology (3 posts)
- Chemistry (72 posts)
- Environtment (3 posts)
- et cetera (5 posts)
- Health (20 posts)
- Nanomaterial (312 posts)
- Physics (33 posts)
Comments
- No comments yet.
Be the first to comment!
Recent Posts
- Using robots, scientists assemble promising antimicrobial compounds
- Light-powered healing of a wearable electrical conductor
- Graphene oxide biodegrades with help of human enzymes
- New tool measures distance between phonon collisions
- Umbrella-shaped diamond nanostructures make efficient photon collectors: Tiny, luminescent nanostructures may prove to be useful in highly sensitive magnetic sensors or within the realm of quantum computing
- First steps to create biodegradable displays for electronics
- Patterning oxide nanopillars at the atomic scale by phase transformation
- Microscopic view of coughed-up mucus may be new biomarker for cystic fibrosis progression
- New research could revolutionize flexible electronics, solar cells
- Nanocircuitry grown with semiconducting graphene nanoribbons
